American Portfolios Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

American Portfolios Advisors’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$16.9K	Hold	75	–	–	﹤0.01%	2274
2022 Q2	$14.2K	Sell	75 -50	-40%	-$10.1K	﹤0.01%	2407
2022 Q1	$31.1K	Buy	125 +50	+67%	+$7.9K	﹤0.01%	2129
2021 Q4	$11.7K	Hold	75	–	–	﹤0.01%	2565
2021 Q3	$15K	Hold	75	–	–	﹤0.01%	2405
2021 Q2	$19.2K	Hold	75	–	–	﹤0.01%	2243
2021 Q1	$19.9K	Hold	75	–	–	﹤0.01%	2074
2020 Q4	$27.7K	Hold	75	–	–	﹤0.01%	1671
2020 Q3	$18.3K	Buy	75 +51	+213%	+$15.9K	﹤0.01%	1731
2020 Q2	$6.96K	Buy	24 +4	+20%	+$1.18K	﹤0.01%	2093
2020 Q1	$4.08K	Hold	20	–	–	﹤0.01%	2175
2019 Q4	$8.94K	Hold	20	–	–	﹤0.01%	2044
2019 Q3	$6.15K	Buy	20 +13	+186%	+$4.22K	﹤0.01%	2116
2019 Q2	$2.12K	Hold	7	–	–	﹤0.01%	2461
2019 Q1	$2.8K	Hold	7	–	–	﹤0.01%	2281
2018 Q4	$2.03K	Hold	7	–	–	﹤0.01%	2136
2018 Q3	$2.4K	Buy	+7	New	+$2.39K	﹤0.01%	2200

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

American Portfolios Advisors's EIGR Position: Q3 2022 in Review

American Portfolios Advisors held its Eiger BioPharmaceuticals, Inc. (EIGR) position steady in Q3 2022 at 75 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

American Portfolios Advisors first reported a position in EIGR in Q3 2018 and has held it in 17 quarters since. The position peaked at $31.1K in Q1 2022. 92 funds tracked by Wall St. Rank hold EIGR as of Q3 2022.

American Portfolios Advisors held 75 shares of Eiger BioPharmaceuticals, Inc. worth $16.9K as of Q3 2022.
American Portfolios Advisors left its Eiger BioPharmaceuticals, Inc. share count unchanged in Q3 2022.
Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2274 holding.
American Portfolios Advisors first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2018 and has held it in 17 quarters since.
American Portfolios Advisors's Eiger BioPharmaceuticals, Inc. position peaked at $31.1K in Q1 2022.
92 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.